Showing results (341-350 of 531) with videos related to
Sort By:
Pageof 54
Radiology|May 1, 1991
Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imagingE S Siegelman, D G Mitchell, R Rubin, et al.Microbiome|January 25, 2022
Enhanced IgA coating of bacteria in women with Lactobacillus crispatus-dominated vaginal microbiotaAnnelot C Breedveld, Heleen J Schuster, Robin van Houdt, et al.Journal of Hematology & Oncology|November 4, 2017
Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)Michael Wang, Stephen J Schuster, Tycel Phillips, et al.Cancer Biology & Therapy|December 14, 2007
Primary cardiac lymphoma: utility of multimodality imaging in diagnosis and managementAnthony R Mato, Alicia K Morgans, Michele R Roullet, et al.Lasers in Surgery and Medicine|June 18, 2009
Trends in retinal damage thresholds from 100-millisecond near-infrared laser radiation exposures: a study at 1,110, 1,130, 1,150, and 1,319 nmRebecca L Vincelette, Benjamin A Rockwell, Jeff W Oliver, et al.Transplantation|May 26, 2001
Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patientsD E Tsai, C L Hardy, J E Tomaszewski, et al.Cancer Medicine|November 18, 2021
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trialSriram Balasubramanian, Brendan Hodkinson, Stephen J Schuster, et al.International Archives of Occupational and Environmental Health|June 16, 2022
Working conditions in low risk nulliparous women in The Netherlands: are legislation and guidelines a guarantee for a healthy working environment? A cohort studyMonique D M van Beukering, Heleen J Schuster, Myrthe J C S Peelen, et al.Molecular Psychiatry|September 20, 2017
An in vitro model of lissencephaly: expanding the role of DCX during neurogenesisM Shahsavani, R J Pronk, R Falk, et al.The New England Journal of Medicine|November 5, 2015
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell LymphomaJia Ruan, Peter Martin, Bijal Shah, et al.Pageof 54